Oncology Institute Inc (TOI)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-06-09 | 2025-06-05 | S Sale | Non-Executive Director Large shareholder |
76,324
-5.7%
3.05USD 232,788 |
76,324 -5.7% | 3.05 | USD 232,788 | |
| 2025-06-09 | 2025-06-05 | S Sale | Non-Executive Director Large shareholder |
673,676
-4.6%
3.05USD 2,054,712 |
673,676 -4.6% | 3.05 | USD 2,054,712 | |
| 2025-06-05 | 2025-06-03 | S Sale | Non-Executive Director |
108,532
-15.2%
2.87USD 311,519 |
108,532 -15.2% | 2.87 | USD 311,519 | |
| 2025-06-05 | 2025-06-03 | S Sale | Non-Executive Director |
1,867,605
-72.4%
2.87USD 5,360,587 |
1,867,605 -72.4% | 2.87 | USD 5,360,587 | |
| 2025-05-22 | 2025-05-20 | S Sale | Non-Executive Director Large shareholder |
203,532
-13.1%
2.71USD 552,162 |
203,532 -13.1% | 2.71 | USD 552,162 | |
| 2025-05-22 | 2025-05-20 | S Sale | Non-Executive Director Large shareholder |
1,796,468
-10.9%
2.71USD 4,873,638 |
1,796,468 -10.9% | 2.71 | USD 4,873,638 | |
| 2025-03-28 | 2025-03-26 | B Purchase |
Chief Executive Officer Officer |
22,640
+3.2%
1.04USD 23,584 |
22,640 +3.2% | 1.04 | USD 23,584 | |
| 2025-03-28 | 2025-03-26 | B Purchase | Non-Executive Director |
90,562
+67.4%
1.04USD 94,338 |
90,562 +67.4% | 1.04 | USD 94,338 | |
| 2025-03-28 | 2025-03-26 | B Purchase |
Chief Medical Officer Officer |
9,056
+12.9%
1.04USD 9,434 |
9,056 +12.9% | 1.04 | USD 9,434 | |
| 2025-03-28 | 2025-03-26 | B Purchase | Non-Executive Director |
9,056
+1.4%
1.04USD 9,434 |
9,056 +1.4% | 1.04 | USD 9,434 | |
| 2025-03-28 | 2025-03-26 | B Purchase |
Chief Operating Officer Officer |
9,056
+11.1%
1.04USD 9,434 |
9,056 +11.1% | 1.04 | USD 9,434 | |
| 2025-03-28 | 2025-03-26 | B Purchase | Non-Executive Director |
36,224
+21.7%
1.04USD 37,735 |
36,224 +21.7% | 1.04 | USD 37,735 | |
| 2025-03-28 | 2025-03-26 | B Purchase |
Chief Financial Officer Officer |
9,056
+29.8%
1.04USD 9,434 |
9,056 +29.8% | 1.04 | USD 9,434 | |
| 2025-03-28 | 2025-03-26 | B Purchase | Non-Executive Director |
1,358,448
+325.6%
1.04USD 1,415,095 |
1,358,448 +325.6% | 1.04 | USD 1,415,095 | |
| 2024-12-02 | 2024-12-02 | B Purchase | Non-Executive Director |
50,000
+8.1%
0.15USD 7,500 |
50,000 +8.1% | 0.15 | USD 7,500 | |
| 2024-12-02 | 2024-11-26 | B Purchase | Non-Executive Director |
250,000
+68.2%
0.17USD 42,500 |
250,000 +68.2% | 0.17 | USD 42,500 | |
| 2024-01-30 | 2024-01-29 | S Sale |
Havencrest Healthcare Partners, L.P. Large shareholder |
8,637
-100.0%
2.12USD 18,310 |
8,637 -100.0% | 2.12 | USD 18,310 | |
| 2024-01-26 | 2024-01-26 | S Sale |
Havencrest Healthcare Partners, L.P. Large shareholder |
6,979
-44.7%
2.14USD 14,935 |
6,979 -44.7% | 2.14 | USD 14,935 | |
| 2024-01-26 | 2024-01-25 | S Sale |
Havencrest Healthcare Partners, L.P. Large shareholder |
11,882
-43.2%
2.07USD 24,596 |
11,882 -43.2% | 2.07 | USD 24,596 | |
| 2024-01-26 | 2024-01-24 | S Sale |
Havencrest Healthcare Partners, L.P. Large shareholder |
24,915
-47.5%
2.30USD 57,305 |
24,915 -47.5% | 2.30 | USD 57,305 |